62321-92-0

Usage

Uses

Used in Pharmaceutical Industry:
2-Cyano-3-(dimethylamino)-2-butenamide is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs. Its unique structure allows it to act as a ligand or building block, enhancing the properties and effectiveness of the resulting medications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Cyano-3-(dimethylamino)-2-butenamide is employed as an intermediate in the production of agrochemicals, aiding in the creation of more effective and targeted pest control solutions.
Used in Research and Development:
2-Cyano-3-(dimethylamino)-2-butenamide is utilized as a reagent in organic synthesis within research and development activities. Its application facilitates the exploration of new chemical reactions and the synthesis of novel compounds, advancing the fields of chemistry and related disciplines.

InChI:InChI=1/C7H11N3O/c1-5(10(2)3)6(4-8)7(9)11/h1-3H3,(H2,9,11)/b6-5+

Upstream product

• 18871-66-4 N,N-dimethylacetamide dimethyl acetal 
• 107-91-5 cyanoacetic acid amide 

Downstream Products

• 103607-63-2 α-Cyano-β-aminocrotonamide 
• 103607-61-0 α-Cyano-β-aminocrotonamide 
• 908808-35-5 5-amino-3-methyl-1H-pyrazole-4-carboxamide 
• 50427-81-1 5-amino-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid amide 
• 62321-91-9 C₈H₉N₃O 
• 98694-78-1 C₉H₁₁N₃O 
• 376621-89-5 2-cyano-3-(3-fluoroanilino)crotonamide 
• 1292297-38-1 4-(3-fluoroanilino)-2-oxo-1,2-dihydropyridine-3-carbonitrile 
• 1292297-39-2 4-(3,4-difluoroanilino)-2-oxo-1,2-dihydropyridine-3-carbonitrile 
• 1292297-43-8 2-chloro-4-(3-fluoroanilino)pyridine-3-carbonitrile 
• 1292297-45-0 2-chloro-4-(3,4-difluoroanilino)pyridine-3-carbonitrile 
• 1292297-48-3 methyl 3-amino-4-(3-fluoroanilino)thieno[2,3-b]pyridine-2-carboxylate 
• 1292297-49-4 methyl 3-amino-4-(3,4-difluoroanilino)thieno[2,3-b]pyridine-2-carboxylate 
• 1292297-53-0 methyl 3-[1-(dimethylamino)ethylidene]amino-4-(3-fluoroanilino)thieno[2,3-b]pyridine-2-carboxylate 

Relevant academic research and scientific papers

CPAP-TUBULIN MODULE

The invention relates to CPAP-tubulin inhibitors having the general formula (1) or a physiologically acceptable salt thereof; and their use as cancer therapeutics.

FUSED TRICYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS

In its many embodiments, the present invention provides tricyclic compounds of formula I (wherein J1-J3, X, Z, and R1-R4 are as defined herein) useful as metabotropic glutamate receptor (mGluR) antagonists, part

Fused tricyclic mGIuR1 antagonists as therapeutic agents

In its many embodiments, the present invention provides tricyclic compounds of formula I (wherein J1-J3, X, Z, and R1, R3, and R4 are as defined herein) useful as metabotropic glutamate receptor (mGlu

mGluR1 antagonists as therapeutic agents

In its many embodiments, the present invention provides tricyclic compounds of formula I (wherein J1-J4, X, and R1—R5 are as defined herein) useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds and compositions to treat diseases associated with metabotropic glutamate receptor (e.g., mGluR1) such as, for example, pain, migraine, anxiety, urinary incontinence and neurodegenerative diseases such Alzheimer's disease.